Viewing Study NCT02482168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-02-22 @ 9:04 AM
Study NCT ID: NCT02482168
Status: COMPLETED
Last Update Posted: 2023-12-20
First Post: 2015-06-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the CD40 Agonistic Monoclonal Antibody APX005M
Sponsor: Apexigen America, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None NSCLC View
None Melanoma View
None Urothelial Carcinoma View
None MSI-H View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None immunotherapy View
None CD40 View